Atlas Trials

Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition

Clinical trial NCT03275597 · TERMINATED

Trial details

NCT number
NCT03275597
Sponsor
University of Wisconsin, Madison
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Non-small Cell Lung CancerNon-small Cell Lung Cancer Stage IV
Start date
2018-02-20
Primary completion
2020-07-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.